tiprankstipranks
Alkermes price target lowered to $28 from $29 at BofA
PremiumThe FlyAlkermes price target lowered to $28 from $29 at BofA
27d ago
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
Premium
The Fly
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
27d ago
Alkermes price target lowered to $30 from $32 at Goldman Sachs
Premium
The Fly
Alkermes price target lowered to $30 from $32 at Goldman Sachs
27d ago
Alkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
PremiumThe FlyAlkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
1M ago
Alkermes Unveils Orexin Portfolio for Sleep Disorders
Premium
Company Announcements
Alkermes Unveils Orexin Portfolio for Sleep Disorders
1M ago
Alkermes management to meet with Piper Sandler
Premium
The Fly
Alkermes management to meet with Piper Sandler
2M ago
Alkermes price target raised to $38 from $37 at Baird
PremiumThe FlyAlkermes price target raised to $38 from $37 at Baird
4M ago
Alkermes price target raised to $37 from $35 at H.C. Wainwright
Premium
The Fly
Alkermes price target raised to $37 from $35 at H.C. Wainwright
4M ago
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
Premium
The Fly
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100